Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Preclinical Blood Test IDs Risk for Respiratory Death, Incident COPD

A proteomic signature indicating increased respiratory susceptibility identifies the risk for respiratory death, incident chronic obstructive pulmonary disease

Weekly Insulin Injections As Effective for Diabetes as Daily Shots, Studies Show

all while lowering A1C. These results can make a significant impact for people living with type 2 diabetes looking for a once-weekly option that provides simila

Good Maternity Care Increasingly Tough to Find in U.S.

a tragedy exacerbated by a lack of resources to care for them, let alone save them, Tatyana Ali, American actress ( Fresh Prince of Bel Air ) and March of Dimes

Daily Pill Helps People Lose Weight, Combines GLP-1 With Other Drug

An experimental weight-loss pill appears to help people quickly shed pounds, a new study says.People who took the drug amycretin lost up to 13 of their body wei

Weight-Loss Pill Saxenda Helps Kids as Young as 6

but when used alone, the effect is modest and, as yet, no medication is approved for the treatment of general obesity in children who are younger than 12. Lirag

FDA to Investigate Safety of Toxic Metals in Tampons

The U.S. Food and Drug Administration announced Tuesday that it will launch an independent review into any possible effects of toxic metals found in tampons.The

Dupixent Phase 3 Trial Confirms Significant Improvements in Itch and Hives for Patients with Chronic Spontaneous Urticaria

TARRYTOWN, N.Y. and PARIS, Sept. 11, 2024. Regeneron Pharmaceuticals, Inc. and Sanofi today announced that a Dupixent (dupilumab) confirmatory Phase 3 trial (LI

First Patient Enrolled in Phase 1b/2 Triplet Therapy Trial of REZLIDHIA in mIDH1 AML

SOUTH SAN FRANCISCO, Calif., Sept. 5, 2024. Rigel Pharmaceuticals, a commercial stage biotechnology company focused on hematologic disorders and cancer, today a

Ifinatamab Deruxtecan Continues to Demonstrate Promising Objective Response Rates in Patients with Extensive-Stage Small Cell Lung Cancer in IDeate-Lung01 Phase 2 Trial

BASKING RIDGE, N.J. RAHWAY, N.J., September 7, 2024 Results from an interim analysis of the dose-optimization part of the ongoing IDeate-Lung01 phase 2 trial sh

Novel Computational Pathology-Based TROP2 Biomarker for Datopotamab Deruxtecan Was Predictive of Clinical Outcomes in Patients With Non-Small Cell Lung Cancer in TROPION-Lung01 Phase III Trial

Results from an exploratory analysis of the TROPION-Lung01 Phase III trial showed TROP2 as measured by AstraZeneca s proprietary computational pathology platfor

Popular Keywords